Aggregation and neurotoxicity of α-synuclein and related peptides

EI-Agnaf, O. M. A., Irvine, G. B.·2002·Biochemical Society Transactions
DOI 10.1042/bst0300559

Cited by (152)

Items 101–152 of 152

  1. Biomarkers for detection, prognosis and therapeutic assessment of neurological disorders
    Sarita G. Singh, Sunil Kumar Gupta, Prahlad Kishore Seth · 2018 · Reviews in the Neurosciences
  2. Exploring binding mechanism of naringenin to human transferrin using combined spectroscopic and computational methods: Towards therapeutic targeting of neurodegenerative diseases
    Shama Khan, Fahad Abdulrahman Alhumaydhi, Mohd Shahnawaz Khan, Sharaf E. Sharaf, Waleed Al Abdulmonem, Md. Imtaiyaz Hassan, Anas Shamsi, Dharmendra Kumar Yadav · 2022 · Journal of Molecular Liquids
  3. Selenomethionine Prevents Degeneration Induced by Overexpression of Wild-Type Human α-Synuclein during Differentiation of Neuroblastoma Cells
    Bipin Kumar, Piruz Nahreini, Amy J. Hanson · 2005 · Journal of the American College of Nutrition
  4. Mapping the Research of Ferroptosis in Parkinson’s Disease from 2013 to 2023: A Scientometric Review
    Yingfan Chen, Zhenhui Wu, Shaodan Li, Qi Chen, Liang Wang, Xiaorong Qi, Chujiao Tian, Minghui Yang · 2024 · Drug Design Development and Therapy
  5. Over-expression of α-synuclein 98 triggers intracellular oxidative stress and enhances susceptibility to rotenone
    Kaili Ma, Yu‐He Yuan, Lian-Kun Song, Ning Han, Nai‐Hong Chen · 2011 · Neuroscience Letters
  6. Target-binding behavior of IDPs via pre-structured motifs
    Do-Hyoung Kim, Kyou‐Hoon Han · 2021 · Progress in molecular biology and translational science
  7. Role of SARS-CoV-2 in Modifying Neurodegenerative Processes in Parkinson’s Disease: A Narrative Review
    Jeremy M. Morowitz, Kaylyn Pogson, Daniel Roque, Frank Church · 2022 · Brain Sciences
  8. Study of the disassembly–assembly process of α-synuclein fibrils by in situ atomic force microscopy
    Lin Tang, Hongtao Li, Hai‐Ning Du · 2006 · Micron
  9. Update from the GHMonitorSM observational registry in children treated with recombinant human growth hormone (Saizen).
    Leslie Plotnick, Robert Rapaport, Paul Desrosiers, John S. Fuqua · 2009 · PubMed
  10. The Aggregation Continuum of α-Synuclein and Its Relevance to Brain Aging
    Anika Rana, Tejas Nikam, Bhargavi Sreepathi, Shubhini Awasthi Saraf, Saurabh Awasthi · 2025 · ACS Chemical Neuroscience
  11. Evaluation of molecular mechanisms responsible for in vivo anti-Alzheimer’s property of Euphorbia cotinifolia methanol extract
    Malik Saadullah, Muhammad Fakhar-e-alam, Saima Muzammil, Muhammad Asif, Muhammad Hussnain Siddique, Muhammad Rashad, Muhammad Mudasir Atif, Abid Hussain Sayyid, Muhammad Afzal · 2023 · Journal of King Saud University - Science
  12. Protein Quality Control by the Ubiquitin Proteolytic Pathway: Roles in Resistance to Oxidative Stress and Disease
    Fu Shang, Edward J. Dudek, Qing Lin Liu, Michael E. Boulton, Allen Taylor · 2006 · Israel Journal of Chemistry
  13. Bridging Molecular Genetics and Biomarkers in Lewy Body and Related Disorders
    G. Ho, W. Liang, M. Waragai, K. Sekiyama, E. Masliah, M. Hashimoto · 2011 · International Journal of Alzheimer's Disease
  14. Bioinformatics aggregation predictors in the study of protein conformational diseases of the human nervous system
    Diego Guidolin, Luigi F. Agnati, Giovanna Albertin, Cinzia Tortorella, Kjell Fuxé · 2012 · Electrophoresis
  15. Oligomeropathies, inflammation and prion protein binding
    Gianluigi Forloni, Pietro La Vitola, Claudia Balducci · 2022 · Frontiers in Neuroscience
  16. Dynamical properties of α-synuclein in soluble and fibrillar forms by Quasi Elastic Neutron Scattering
    Luc Bousset, Clémence Brewee, Ronald Melki, F. Migliardo · 2014 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  17. Crystals of a toxic core
    Michel Goedert, Yifan Cheng · 2015 · Nature
  18. Pathways to Amyloid Fibril Formation: Partially Folded Intermediates in the Fibrillation of Natively Unfolded Proteins
    Vladimir Nikolaevich Uversky, Anthony L. Fink · 2005 · Wiley eBooks
  19. Structural analyses and force fields comparison for NACore (68–78) and SubNACore (69–77) fibril segments of Parkinson’s disease
    Hakan Alıcı · 2020 · Journal of Molecular Modeling
  20. Subcortical Iron Accumulation Pattern May Predict Neuropsychological Outcomes After Subthalamic Nucleus Deep Brain Stimulation: A Pilot Study
    Gregory L. Brown, Guangwei Du, Elana Farace, Mechelle M. Lewis, Paul J. Eslinger, James McInerney, Lan Kong, Runze Li, Xuemei Huang, Sol De Jesus · 2021 · Journal of Parkinson s Disease
  21. Studies on alpha-synuclein and islet amyloid polypeptide interaction
    Ye Wang, Joakim J. E. Bergström, Martin Ingelsson, Gunilla Torstensdotter Westermark · 2023 · Frontiers in Molecular Biosciences
  22. Adsorption of alpha-synuclein and inhibition of fibril formation by nanocellulose and gold-coated-nanocellulose
    Elika Lamtar Mohammadi, Reza Keikha, Tiago F. Outeiro · 2024 · Cellulose
  23. A New Interpretative Paradigm for Conformational Protein Diseases
    Luigi F. Agnati, Diego Guidolin, Amina S. Woods, Francisco Ciruela, Chiara Carone, Annamaria Vallelunga, Dasiel Oscar Borroto Escuela, Susanna Genedani, Kjell Fuxé · 2013 · Current Protein and Peptide Science
  24. Protein Aggregation Disorders
    Tiago F. Outeiro, Pamela J. McLean, Bradley T. Hyman · 2007 · Elsevier eBooks
  25. Differentially heterogeneous hydration environment of the familial mutants of α-synuclein
    Leena Aggarwal, Sayan Karmakar, Parbati Biswas · 2024 · The Journal of Chemical Physics
  26. Mechanism of Aggregation of the NACore of α-Synuclein: Stable Oligomer Formation Competes with Fibril Formation with Implications for the Etiology of Parkinson’s Disease
    Yingying Jin, Pritam Ganguly, Lena Wessel, Zhiyuan Zhu, Anouk M. Rijs, Joan‐Emma Shea, Steven K. Buratto, Michael T. Bowers · 2026 · Journal of the American Chemical Society
  27. Synergetic Treatment of Ascorbic Acid and Nicotine Ameliorates Aluminium Induced Neurotoxicity in the Prefrontal Cortex of Wistar Rat
    T. Abayomi · 2021 · Pan African Journal of Life Sciences
  28. Amyloid Polymorphism of α-Synuclein Induced by Active Firefly Luciferase
    Jee Eun Yang, Je Won Hong, Jehoon Kim, Seung R. Paik · 2014 · Bulletin of the Korean Chemical Society
  29. 6Chapter Micronutrients for the Prevention of Diabetes and Improvement of the Standard Therapy
    Kedar N. Prasad · 2010 · CRC Press eBooks
  30. Amyloidogenic Pattern Prediction of HIV-1 Proteins
    Patil Sneha, S. Balaji, Paul Shapshak · 2017 · Springer eBooks
  31. Non-steric-zipper models for pathogenic α-synuclein conformers
    Brock Schuman, Amy M. Won, Koroboshka Brand‐Arzamendi · 2018 · APL Bioengineering
  32. Micronutrients for the Prevention and Improvement of the Standard Therapy for Parkinson’s Disease
    Kedar Nath Prasad · 2019 · CRC Press eBooks
  33. Amyloid Fibril Formation of Natively Unfolded Proteins
    Vladimir Nikolaevich Uversky, Anthony L. Fink · 2008 · Protein Science Encyclopedia
  34. Folding on the Assembly Line
    Elisha Haas · 2008 · ACS Chemical Biology
  35. Pesticides and Pesticide Mixtures Induce Neurotoxicity: Potentiation of Apoptosis and Oxidative Stress
    Zhenquan Jia · 2006 · VTechWorks (Virginia Tech)
  36. Iron Homeostasis and Neurodegeneration
    Robert R. Crichton · 2016
  37. Conformational Ensemble of Monomeric α -Synuclein in Aqueous and Crowded Environments as revealed by Markov State Model
    Sneha Menon, Jagannath Mondal · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  38. Longitudinal changes of iron in the substantia nigra of early-stage Parkinson’s disease
    Guangwei Du, Christopher T. Sica, Sol De Jesus · 2026 · medRxiv
  39. Brain Dysfunction Associated with Amyloid Fibrils and Other Aggregated Proteins
    Giorgio Giaccone, Mario Salmona, Fabrizio Tagliavini, Gianluigi Forloni · 2005 · Wiley eBooks
  40. Protein Aggregates in Neurodegenerative Disorders
    Giorgio Giaccone, Mario Salmona, Fabrizio Tagliavini, Gianluigi Forloni · 2008 · Wiley eBooks
  41. Détection et caractérisation de peptides obliques au sein des protéines amyloïdogéniques
    Jean‐Marc Crowet, Robert Brasseur, Laurence Lins · 2008
  42. Etude expérimentale du peptide oblique de l'α-synucléine
    Agronomiques De Gembloux · 2004
  43. COMMUNAUTE FRANÇAISE DE BELGIQUE ACADEMIE UNIVERSITAIRE WALLONIE-EUROPE FACULTE UNIVERSITAIRE DES SCIENCES AGRONOMIQUES DE GEMBLOUX Détection et caractérisation de peptides obliques au sein de protéines amyloïdogéniques
    Jean‐Marc Crowet · 2008
  44. Simultaneous Activation of Nrf2 and Elevation of Dietary and Endogenous Antioxidants for Prevention and Improved Management of Parkinson’s Disease
    Kedar Nath Prasad · 2016 · Oxidative stress in applied basic research and clinical practice
  45. Modification of α-Synuclein by Phosphorylation: A Pivotal Event in the Cellular Pathogenesis of Parkinson’s Disease
    Indrani Datta, Kavina Ganapathy · 2017 · InTech eBooks
  46. References
    2009 · Chapman & Hall/CRC eBooks
  47. 10.1063/1.5023460.1
    Brock Schuman, Amy M. Won, Koroboshka Brand‐Arzamendi · 2018 · Default Digital Object Group
  48. Etude de la relation structure - toxicité des protéines amyloïdes en interaction avec des membranes modèles
    Ha Phuong Ta · 2011
  49. Etude de l'interaction du TIMP-1 avec ses récepteurs
    Laurie Verzeaux · 2015
  50. Étude moléculaire de la propagation de l’agrégation de l’alpha-synucléine dans un modèle transgénique de la maladie de Parkinson : impact de la surexpression de la beta-synucléine à l’aide de vecteurs viraux adéno-associés (AAV)
    Dorian Sargent · 2018 · theses.fr (ABES)
  51. Early Detection of Parkinson's Disease through Microfluidics and Ion Mobility - Mass Spectrometry Integration
    Isabel De Figueiredo · 2024 · theses.fr (ABES)
  52. Longitudinal Iron Changes in the Substantia Nigra of Early‐Stage Parkinson's Disease
    Guangwei Du, Christopher T. Sica, Sol De Jesus · 2026 · Movement Disorders